Synthesis and anti-mycobacterial activity of novel amino alcohol derivatives

European Journal of Medicinal Chemistry

Volumn 46, Issue 3, 2011, Pages 974-978

  Cunico, Wilson ^a,c   Gomes, Claudia R B ^a   Ferreira, Maria L G ^a   Ferreira, Thaís G ^a   Cardinot, Danielle ^a   De Souza, Marcus V N ^a   Loureno, Maria C S ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Amino alcohols; Hydroxyethylamines; Tuberculosis

Indexed keywords

AMINOALCOHOL; ETHAMBUTOL; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

EID: 79951681439     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.01.004     Document Type: Article

References (20)

1. M.L. Ferreira, T.R.A. Vasconcelos, E.M. de Carvalho, M.C.S. Loureno, S.M.S.V. Wardell, J.L. Wardell, V.F. Ferreira, and M.V.N. de Souza Synthesis and antitubercular activity of novel Schiff bases derived from d-mannitol Carbohydr. Res. 344 2009 2042 2047
2. P.S.M. de Oliveira, V.F. Ferreira, M.V.N. de Souza, and E.M. de Carvalho Síntese de aminoálcoois derivados do d-manitol Quim. Nova 31 2008 776 780
3. A. Brik, and C.-H. Wong HIV-1 protease: mechanism and drug discovery Org. Biomol. Chem. 1 2003 5 14
4. A.K. Ghosh, G. Bilcer, and G. Schiltz Synthesis of FDA approved HIV protease inhibitors Synthesis 2001 2203 2229 (Pubitemid 33081858)
5. S. Parikh, J. Gut, E. Istvan, D.E. Goldberg, D.V. Havlir, and P.J. Rosenthal Antimalarial activity of human immunodeficiency virus Type 1 protease inhibitors Antimicrob. Agents Chemother. 49 2005 2983 2985 (Pubitemid 40917621)
6. K.T. Andrews, D.P. Fairlie, P.K. Madala, J. Ray, D.M. Wyatt, P.M. Hilton, L.A. Melville, L. Beattie, D.L. Gardioner, R.C. Reid, M.J. Stoermer, T. Skinner-Adams, C. Berry, and J.S. McCarthy Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria Antimicrob. Agents Chemother. 50 2006 639 648 (Pubitemid 43190977)
7. D. Noteberg, E. Hamelink, J. Hulten, M. Wahlgren, L. Vrang, B. Samuelsson, and A. Hallberg Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes J. Med. Chem. 46 2003 734 746 (Pubitemid 36258865)
8. D. Savoia, T. Allice, and P.-A. Tovo Antileishmanial activity of HIV protease inhibitors Int. J. Antimicrob. Agents 26 2005 92 94 (Pubitemid 40854125)
9. W. Cunico, C.R.B. Gomes, M. Moreth, D.P. Manhanini, I.H. Figueiredo, C. Penido, M.G.M.O. Henriques, F.P. Varotti, and A.U. Krettli Synthesis and antimalarial activity of hydroxyethylpiperazine derivatives Eur. J. Med. Chem. 44 2009 1363 1368
10. W. Cunico, M.L.G. Ferreira, T.G. Ferreira, C. Penido, M.G.M.O. Henriques, L.G. Krettli, F.P. Varotti, and A.U. Krettli Synthesis and antimalarial activity of novel hydroxyethylamines, potential aspartyl protease inhibitors Lett. Drug Des. Discov. 5 2008 178 181 (Pubitemid 351536327)
11. W. Cunico, C.R.B. Gomes, V. Facchinetti, M. Moreth, C. Penido, M.G.M.O. Henriques, F.P. Varotti, L.G. Krettli, A.U. Krettli, F.S. da Silva, E.R. Caffarena, and C.S. de Magalhães Synthesis, antimalarial evalution and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2 Eur. J. Med. Chem. 44 2009 3816 3820
12. R. Yendapally, and R.E. Lee Design, synthesis and evaluation of novel ethambutol analogues Bioorg. Med. Chem. Lett. 18 2008 1607 1611 (Pubitemid 351318253)
13. R.E. Lee, M. Protopopova, E. Crooks, R.A. Slayden, M. Terrot, and C.E. Barry III Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates J. Comb. Chem. 5 2003 172 187 (Pubitemid 37123511)
14. H.I. Boshoff, T.G. Myers, B.R. Copp, M.R. McNeil, M.A. Wilson, and C.E. Barry III The transcriptional responses of mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action J. Biol. Chem. 279 2004 40174 40184 (Pubitemid 39258293)
15. M.V.N. De Souza, and T.R.A. Vasconcelos Fármacos no combate tuberculose: passado, presente e futuro Quim. Nova 28 2005 678 682 (Pubitemid 41127640)
16. M.V.N. De Souza Promising drugs against tuberculosis Recent Pat. Anti-Infect. Drug Discov. 1 2006 33 44
17. M.V.N. De Souza Current status and future prospects for new therapies for pulmonary tuberculosis Curr. Opin. Pulm. Med. 12 2006 167 171 (Pubitemid 44350470)
18. S.G. Franzblau, R.S. Witzig, J.C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M.T. Degnan, M.B. Cook, V.K. Quenzer, R.M. Ferguson, and R.H. Gilman Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar blue assay J. Clin. Microbiol. 36 1998 362 366 (Pubitemid 28060296)
19. J.D. Vanitha, and C.N. Paramasivan Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates Diagn. Microbiol. Infect. Dis. 49 2004 179 182 (Pubitemid 38891724)
20. R.S. Reis, I. Neves Jr., S.L.S. Loureno, L.S. Fonseca, and M.C.S. Loureno Comparison of flow cytometric and Alamar blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid J. Clin. Microbiol. 42 2004 2247 2248 (Pubitemid 38637855)